Interview quality and signal detection in clinical trials.
Kobak
Kenneth A
KA
Feiger
Alan D
AD
Lipsitz
Joshua D
JD
D000928:Antidepressive Agents / Q000494:pharmacology / Q000627:therapeutic use; D017322:Clinical Trials, Phase II as Topic / Q000379:methods / Q000592:standards*; D003866:Depressive Disorder / Q000188:drug therapy / Q000523:psychology; D006801:Humans; D007406:Interview, Psychological / Q000592:standards; D015337:Multicenter Studies as Topic; D017063:Outcome Assessment, Health Care / Q000379:methods / Q000592:standards; D017374:Paroxetine / Q000494:pharmacology / Q000627:therapeutic use; D015990:Placebo Effect; D010919:Placebos / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales / Q000592:standards*; D011786:Quality Control; D017603:Signal Detection, Psychological / Q000187:drug effects; D049269:Videoconferencing / Q000592:standards
D000928:Antidepressive Agents; D010919:Placebos; D017374:Paroxetine